The effect of drug resistance on the fitness of Mycobacterium tuberculosis.
about
Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosisCosts of antibiotic resistance - separating trait effects and selective effectsInfection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the KeyImpact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosisCost-effectiveness of treating multidrug-resistant tuberculosisAntiviral resistance and the control of pandemic influenzaHeightened vulnerability to MDR-TB epidemics after controlling drug-susceptible TBPre-existing isoniazid resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference in vitroBayesian estimation of mixture models with prespecified elements to compare drug resistance in treatment-naïve and experienced tuberculosis casesElucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencingThe importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission modelTransmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort StudyThe Role of Adherence and Retreatment in De Novo Emergence of MDR-TBGenomic Insight into Mechanisms of Reversion of Antibiotic Resistance in Multidrug Resistant Mycobacterium tuberculosis Induced by a Nanomolecular Iodine-Containing Complex FS-1.Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.Drug-susceptibility patterns of Mycobacterium tuberculosis in Mpumalanga province, South Africa: possible guiding design of retreatment regimen.Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populationsPrevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study.Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans.Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis.Models to understand the population-level impact of mixed strain M. tuberculosis infections.Molecular epidemiology of tuberculosis: current insights.Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, ChinaEliminating human tuberculosis in the twenty-first century.Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation diseaseOld and new selective pressures on Mycobacterium tuberculosis.The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig.Fitness Costs of Drug Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis: A Household-Based Case-Control StudyDynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients.A time-to-event pharmacodynamic model describing treatment response in patients with pulmonary tuberculosis using days to positivity in automated liquid mycobacterial cultureAntituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006.Population structure analysis of the Mycobacterium tuberculosis Beijing family indicates an association between certain sublineages and multidrug resistance.Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness.The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach.Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysisEvolution and transmission of drug-resistant tuberculosis in a Russian population.
P2860
Q24170218-561BB764-A04D-4D6B-8A4C-00263CCA7040Q28082095-634F0CE5-3A4A-4692-90A6-65C25FF11FCCQ28393098-85D980FA-2A19-4C91-ABAB-656281AAFA70Q28469011-73495F48-A8B6-4379-8CD4-320133117685Q28469015-F26608DC-D26F-4914-B5ED-A9E792311055Q28469119-8EA75A3C-0618-414D-AAC6-27DF2807EBDEQ28475553-8178370C-65C7-414F-8996-322BA54B3DD4Q28478663-3138C70D-D268-464B-A7E4-3960C6614CCBQ28488592-D6C5E4A2-59BF-4FCC-8D5F-2514123EDD99Q28536869-443521EC-4329-4E8E-B5B9-F0E813623D46Q28540733-B9FD3AF6-BC4C-445A-B328-C0A7CFCD29F2Q28548584-92143972-2A2B-4026-8F9F-E6628A6858A4Q28550707-36120178-F22A-4DBC-BCB6-7B16D1EB482DQ33645712-954833DD-F3C3-449B-A2D1-4E87425E1D68Q33836636-A6616D5A-AD10-4591-89A7-9F2A058349ADQ34288585-C0C7263B-FCAB-431A-8974-302E4D798241Q34598512-B78EED9E-97AB-4056-8614-7A93CEB300CFQ34707237-496CF4B1-2125-4373-BC67-915D8BF0D7DAQ34721695-AD8503B2-D553-4F19-88BB-7853501A791CQ34974987-E198718A-E34C-442A-9B7A-89B78BCB2D62Q34999398-5DC61A07-0A07-40D1-BEAC-7317A3EB04E5Q35037192-9047F95F-0B10-44C2-A8DE-A4206C265627Q35070843-170D9B42-9B3B-45E9-A884-531A4E3064E2Q35210458-DFC0F8B9-6570-4E03-AA91-5C1E71825FCDQ35581410-25567E74-7EFA-4E30-B56A-A38E9E1D7F47Q35584122-4CFBFE96-5B5E-42A6-997E-6C61B58DAFC5Q35659421-C81293D3-364F-4BAA-B8C2-6FA3598ED812Q35881727-734A053B-4D3A-468F-8544-D64FE0F21697Q36070976-661F348F-D37C-4384-A1EE-F3C354FDABCBQ36094198-C208862E-1DD0-4CAD-8674-B111F6EACFDCQ36154683-D688F7F8-2F75-4913-9A9A-223EDC48FF34Q36365273-A280B582-0C85-4283-84ED-F077231E9482Q36368678-61A67225-05D4-41EC-8404-B7B48D6A3A16Q36558478-42851C19-7BF3-4EC3-ABA4-C4EE2680CD3CQ36853870-5799E45F-01B0-4A93-B243-EC81DBD00ABFQ36932942-A199F1FA-FB02-49F2-8A5B-546335C58A34Q37120860-573FCBB2-7454-4761-9D43-12DD88A80CAFQ37208930-1230B957-4DCF-47CF-B70F-513590B934ECQ37473011-4B234586-56F6-47AA-80B6-36590BB7931EQ37611572-DE891410-37F4-4F25-80B1-DE9806110B27
P2860
The effect of drug resistance on the fitness of Mycobacterium tuberculosis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The effect of drug resistance on the fitness of Mycobacterium tuberculosis.
@ast
The effect of drug resistance on the fitness of Mycobacterium tuberculosis.
@en
type
label
The effect of drug resistance on the fitness of Mycobacterium tuberculosis.
@ast
The effect of drug resistance on the fitness of Mycobacterium tuberculosis.
@en
prefLabel
The effect of drug resistance on the fitness of Mycobacterium tuberculosis.
@ast
The effect of drug resistance on the fitness of Mycobacterium tuberculosis.
@en
P2093
P1476
The effect of drug resistance on the fitness of Mycobacterium tuberculosis.
@en
P2093
Ben Sommers
Megan Murray
P356
10.1016/S1473-3099(03)00483-3
P577
2003-01-01T00:00:00Z